Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorth Atl.smlr Regulatory News (NAS)

Share Price Information for North Atl.smlr (NAS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,170.00
Bid: 4,140.00
Ask: 4,230.00
Change: 10.00 (0.24%)
Spread: 90.00 (2.174%)
Open: 4,120.00
High: 4,240.00
Low: 4,120.00
Prev. Close: 4,160.00
NAS Live PriceLast checked at -
North Atlantic Smaller Companies is an Investment Trust

To provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

17 Dec 2013 09:08

RNS Number : 7238V
North Atlantic Smlr Co Inv Tst PLC
17 December 2013
 



NORTH ATLANTIC SMALLER COMPANIES INVESTMENT TRUST PLC

 

INTERIM MANAGEMENT STATEMENT FOR THE PERIOD ENDED 31 OCTOBER 2013

 

To the members of North Atlantic Smaller Companies Investment Trust PLC

This interim management statement has been produced solely to provide additional information to shareholders as a body in accordance with the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.

 

This interim management statement relates to the period from 1 August 2013 to 31 October 2013, and contains information that covers this period, and up to the date of publication of this interim management statement, unless otherwise specified.

 

Investment Objective

The objective of North Atlantic Smaller Companies Investment Trust PLC ("the Company") is to provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

 

Financial Highlights

Cumulative performance

As at

31 October 2013

3 months %

6 months %

1 year 

%

3 years %

5 years %

Diluted NAV*

1,864p 

2.2 

8.4 

25.7

36.7 

84.9 

Mid-market price

1,588p 

6.4 

13.8 

38.0

52.0 

146.2 

Discount to diluted NAV *

14.8% 

Standard & Poor's 500 Composite Index **

1,095.1 

(1.2)

6.5 

25.1

48.4 

81.7 

Russell 2000 **

685.9 

(0.2)

12.4 

35.1

56.4 

105.1 

FTSE All-Share Index

3,585.3 

2.2 

5.8 

18.6

22.1 

64.2 

US Dollar/Sterling exchange rate

1.6066 

(6.0)

(3.2)

0.3

(0.5)

0.6 

 

* Following the conversion of the Loan Notes the performance is shown on the diluted NAV, excluding retained revenue for the period, only. The Board considers that this accurately reflects the underlying performance of the Company

** Sterling adjusted.

 

 

Material Events and Transactions during the Period

 

During the period under review, the Company's holdings in Bionostics and Orthoproducts were sold at a good uplift to the year-end valuation and at a significant premium to cost. As a result, the Company now has cash or near cash balances of circa £80 million.

 

 

Transactions in Own Shares

 

On 26 September 2013, 1,450 Ordinary shares were bought back for cancellation, at a total cost to the Company of £22,000.

 

Since 31 October 2013, a further 13,483 Ordinary shares were bought back for cancellation, in two tranches, at the beginning of December 2013, at a total cost of £208,000.

 

Following these purchases the Company's issued share capital consists of 15,897,501 Ordinary shares.

 

 

 

TEN LARGEST INVESTMENTS AT 31 OCTOBER 2013

Gleeson (MJ) Group

UK Listed

11.5

US Treasury Bills

US Treasury Bills

18.8

Oryx International Growth Fund Limited *

UK Listed

11.5

Trident Private Equity Fund III LLP

UK Unquoted

8.3

Hampton Investment Properties Limited

UK Unquoted

5.2

Bioquell

UK Listed

4.7

Guinness Peat Group **

UK Listed

4.5

Celsis AG

US Unquoted

3.5

AssetCo PLC

UK Listed

2.8

Goals Soccer Centres

UK Listed

2.6

% of total portfolio

73.4

 

* incorporated in Guernsey

** incorporated in New Zealand

 

SECTOR ANALYSIS OF INVESTMENTS AT FAIR VALUE AS AT 31 OCTOBER 2013

 

United 

United 

Total 

States 

Kingdom 

Europe 

Investment Companies

20.5

20.5

Treasury Bills

18.8

18.8

Construction & Materials

11.5

11.5

Real Estate

0.2

7.6

0.4

8.2

Support Services

1.0

5.1

6.1

Industrial Engineering

5.1

5.1

Health Care, Equipment & Services

0.2

4.7

4.9

Financial Services

4.5

4.5

Travel & Leisure

3.5

3.5

Media

3.2

3.2

Banks

3.1

3.1

Escrows

1.7

0.4

2.1

Oil & Gas Producers

1.2

0.8

2.0

General Retailers

1.7

1.7

Technology Hardware & Equipment

1.5

1.5

Food Producers

1.3

1.3

Industrial Transportation

1.3

1.3

Business Services

0.7

0.7

 

The financial information for the period ended 31 October 2013 contained within this Interim Management Statement has not been audited.

 

 

By order of the Board

 

 

Bonita Guntrip

Company Secretary

17 December 2013

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGMMMZLNDGFZG
Date   Source Headline
22nd Nov 20219:32 amRNSTransaction in Own Shares
22nd Nov 20219:13 amRNSNet Asset Value(s)
19th Nov 202110:21 amRNSTransaction in Own Shares
15th Nov 20219:34 amRNSTransaction in Own Shares
18th Oct 20212:24 pmRNSTransaction in Own Shares
15th Oct 202110:39 amRNSNet Asset Value(s)
4th Oct 20219:41 amRNSTransaction in Own Shares
27th Sep 20219:05 amRNSTransaction in Own Shares
23rd Sep 202111:02 amRNSMajor liquidity events
16th Sep 20214:22 pmRNSHalf-year Report
15th Sep 202112:06 pmRNSNet Asset Value(s)
16th Aug 202111:33 amRNSNet Asset Value(s)
22nd Jul 20212:00 pmRNSNet Asset Value(s)
25th Jun 20211:15 pmRNSDirector/PDMR Shareholding
23rd Jun 202112:33 pmRNSResult of AGM
23rd Jun 202111:59 amRNSNet Asset Value(s)
15th Jun 20214:38 pmRNSStatement re AGM
20th May 20215:56 pmRNSAnnual Financial Report
19th May 202112:05 pmRNSNet Asset Value(s)
10th May 20215:02 pmRNSAnnual Financial Report
14th Apr 202111:37 amRNSNet Asset Value(s)
8th Apr 20213:05 pmRNSHolding(s) in Company
19th Mar 20219:24 amRNSNet Asset Value(s)
4th Mar 202112:30 pmRNSHolding(s) in Company
19th Feb 202112:55 pmRNSNet Asset Value(s)
11th Feb 20216:00 pmRNSHolding(s) in Company
10th Feb 20215:12 pmRNSTransaction in Own Shares
4th Feb 202112:03 pmRNSTransaction in Own Shares
29th Jan 20215:44 pmRNSTransaction in Own Shares
18th Jan 20213:32 pmRNSHolding(s) in Company
18th Jan 202112:03 pmRNSNet Asset Value(s)
15th Jan 20215:35 pmRNSTransaction in Own Shares
4th Jan 20217:00 amRNSNet Asset Value(s)
24th Dec 202010:41 amRNSTransaction in Own Shares
23rd Dec 20204:09 pmRNSStatement re shareholder engagement
21st Dec 20204:42 pmRNSTransaction in Own Shares
4th Dec 202012:54 pmRNSTransaction in Own Shares
4th Dec 202010:05 amRNSHolding(s) in Company
25th Nov 202011:02 amRNSHolding(s) in Company
23rd Nov 202011:10 amRNSNet Asset Value(s)
12th Nov 20204:34 pmRNSHolding(s) in Company
4th Nov 20203:47 pmRNSDirector/PDMR Shareholding
28th Oct 20209:56 amRNSHolding(s) in Company
27th Oct 20209:43 amRNSTransaction in Own Shares
14th Oct 202012:33 pmRNSNet Asset Value(s)
14th Oct 20208:00 amRNSHolding(s) in Company
7th Oct 20208:47 amRNSTransaction in Own Shares
25th Sep 202012:49 pmRNSNotification of Major Shareholdings
23rd Sep 202011:53 amRNSNet Asset Value(s)
18th Sep 20203:46 pmRNSDoc re Investor Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.